Incidence and magnitude of post-transplant cardiovascular disease after pediatric kidney transplantation: Risk factor analysis of 1058 pediatric kidney transplants at the university of Minnesota

被引:10
|
作者
Serrano, Oscar K. [1 ]
Bangdiwala, Ananta S. [2 ]
Vock, David M. [3 ]
Chinnakotla, Srinath [1 ]
Dunn, Ty B. [1 ]
Finger, Erik B. [1 ]
Kandaswamy, Raja [1 ]
Pruett, Timothy L. [1 ]
Najarian, John S. [1 ]
Matas, Arthur J. [1 ]
Chavers, Blanche [4 ]
机构
[1] Univ Minnesota, Dept Surg, Div Transplantat, Box 242 UMHC, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Masonic Canc Ctr, Biostat & Bioinformat Core, Minneapolis, MN USA
[3] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
关键词
cardiovascular disease; kidney transplant; long-term outcomes; pediatric; LONG-TERM OUTCOMES; RENAL-TRANSPLANTATION; HEART-DISEASE; SINGLE-CENTER; RECIPIENTS; CHILDREN; MORTALITY; COMPLICATIONS; DYSLIPIDEMIA; PREVENTION;
D O I
10.1111/petr.13283
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background KT recipients have increased the risk of CVD. The incidence of post-transplant CVEs among pediatric recipients has not been well-characterized. Patients and MethodsResultsBetween 1963 and 2015, 884 pediatric (age: 0-17years old) recipients received 1058 KTs at our institution. The cumulative incidence of CVEs was analyzed. Statistical models were used to estimate risk factors for developing post-transplant CVEs. Overall median patient survival was 33years (IQR: 18.7-47). A total of 362 CVEs occurred in 161 (18.3%) patients at a median age of 20.5years. Arrhythmias (18%) were most common. Cumulative risk of post-transplant CVEs was 9% at 10years, 17% at 20years, 25% at 30years, and 36% at 40years. Development of post-transplant CVEs was associated with increased mortality (HR 2.25 [95% CI 1.61-3.14]); of those who developed a CVE and died, 22/51 (43.1%) died of CVD. Multivariable risk factors for post-transplant CVEs included a history of pretransplant CVD (aHR 1.92 [1.18-3.13] and graft failure (4.57 [3.13-6.67]). DiscussionA pretransplant history of CVD and a failed graft are significant risk factors for the development of post-transplant CVE. CVD increases the risk of post-transplant death or graft loss.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case-control study
    Origueen, Julia
    Fernandez-Ruiz, Mario
    Lumbreras, Carlos
    Angeles Orellana, Maria
    Lopez-Medrano, Francisco
    Ruiz-Merlo, Tamara
    San Juan, Rafael
    Garcia-Reyne, Ana
    Gonzalez, Esther
    Polanco, Natalia
    Paz-Artal, Estela
    Andres, Amado
    Maria Aguado, Jose
    INFECTION, 2015, 43 (04) : 413 - 422
  • [42] A meta-analysis of the cumulative incidence, risk factors, and clinical outcomes associated with chronic kidney disease after liver transplantation
    Lim, Sze Yinn
    Wang, Renaeta
    Tan, Darren Jun Hao
    Ng, Cheng Han
    Lim, Wen Hui
    Quek, Jingxuan
    Syn, Nicholas
    Nah, Benjamin Kai Yi
    Wong, Emmett Tsz-Yeung
    Huang, Daniel Q.
    Vathsala, Anantharaman
    Siddiqui, Mohammad Shadab
    Fung, James
    Muthiah, Mark D.
    Tan, Eunice Xiang-Xuan
    TRANSPLANT INTERNATIONAL, 2021, 34 (12) : 2524 - 2533
  • [43] Retrospective analysis on incidence and risk factors of post-transplant diabetes mellitus after lung transplantation and its association with clinical outcomes
    Du, Wenwen
    Wang, Xiaoxing
    Zhang, Dan
    Zuo, Xianbo
    TRANSPLANT IMMUNOLOGY, 2024, 83
  • [44] Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis
    Arness, T.
    Pedersen, R.
    Dierkhising, R.
    Kremers, W.
    Patel, R.
    TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (04) : 260 - 268
  • [45] Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus.: Matched-pair design Multicenter study
    Pietrzak-Nowacka, Maria
    Safranow, Krzysztof
    Rozanski, Jacek
    Debska-Slizien, Alicja
    Domaliski, Leszek
    Dziewanowski, Krzysztof
    Glyda, Maciej
    Jankowska, Magdalena
    Nocen, Malgorzata
    Pabisiak, Krzysztof
    Rutkowski, Boleslaw
    Wisniewska, Magda
    Ciechanowsk, Kazimierz
    ARCHIVES OF MEDICAL RESEARCH, 2008, 39 (03) : 312 - 319
  • [46] Risk factors for acute kidney injury in pediatric patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis
    Huang, Baoyi
    Shan, Jiayi
    Yi, Lichen
    Xin, Yijun
    Zhong, Zhishan
    Xu, Hua
    PEDIATRIC NEPHROLOGY, 2024, 39 (02) : 397 - 408
  • [47] Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial
    Dad, Taimur
    Tighiouart, Hocine
    Joseph, Alin
    Bostom, Andrew
    Carpenter, Myra
    Hunsicker, Lawrence
    Kusek, John W.
    Pfeffer, Marc
    Levey, Andrew S.
    Weiner, Daniel E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 68 (02) : 277 - 286
  • [48] Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
    Ali, Salah
    AlThubaiti, Sami
    Renzi, Samuele
    Krueger, Joerg
    Chiang, K. Y.
    Naqvi, Ahmed
    Schechter, Tal
    Punnett, Angela
    Ali, Muhammad
    PEDIATRIC TRANSPLANTATION, 2019, 23 (01)
  • [49] Successful preemptive therapy with single-dose rituximab for Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation
    Kim, Bo Kyung
    Kang, Hyoung Jin
    Hong, Kyung Taek
    An, Hong Yul
    Choi, Jung Yoon
    Lee, Jee Soo
    Park, Sung Sup
    Shin, Hee Young
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (06)
  • [50] Risk Factor Analysis for Long-Term Graft Survival Following Pediatric Kidney Transplantation: The Importance of Pretransplantation Time on Dialysis and Donor/Recipient Age Difference
    Marcou, Marios
    Galiano, Matthias
    Tzschoppe, Anja
    Sauerstein, Katja
    Wach, Sven
    Taubert, Helge
    Wullich, Bernd
    Hirsch-Koch, Karin
    Apel, Hendrik
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)